An update of the leukotriene modulators for the treatment of asthma.

about

The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field.

P2860

Q37016080-2C02C500-DA3D-4788-B7C2-7AFFD21B3575

P2860

An update of the leukotriene modulators for the treatment of asthma.

Item

http://www.wikidata.org/entity/Q35814442

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

An update of the leukotriene modulators for the treatment of asthma.

@ast

An update of the leukotriene modulators for the treatment of asthma.

@en

type

Item

label

An update of the leukotriene modulators for the treatment of asthma.

@ast

An update of the leukotriene modulators for the treatment of asthma.

@en

prefLabel

An update of the leukotriene modulators for the treatment of asthma.

@ast

An update of the leukotriene modulators for the treatment of asthma.

@en

P1476

An update of the leukotriene modulators for the treatment of asthma.

@en

P2093

Carmine Di Ilio

http://www.w3.org/2001/XMLSchema#string

Graziano Riccioni

http://www.w3.org/2001/XMLSchema#string

Nicolantonio D'Orazio

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

Recent advances in the management of asthma using leukotriene modifiers

Aspirin intolerance and the cyclooxygenase-leukotriene pathways

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

P304

763-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.7.763

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15212617

http://www.w3.org/2001/XMLSchema#string

P921

asthma

An update of the leukotriene modulators for the treatment of asthma.

about

P2860

P2860

An update of the leukotriene modulators for the treatment of asthma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921